Uracil/tegafur plus oral calcium folinate in advanced breast cancer
Eduardo Richardet(Instituto Oncológico de Córdoba), Maria Cuevas, E. Mickiewicz(University of Chicago), Alicia Elli, Federico Cóppola(Hospital Alemán), S Jovtis, M. Bruno, Mónica Ventriglia, Miguel Bonamasa, Guillermo Lerzo, Cecilia Pedraza, G Uranga
Academic Production
December 31, 1999
Cited by 0
Related Papers
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer
|New England Journal of Medicine|2004|1.8k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Ixabepilone Plus Capecitabine for Metastatic Breast Cancer Progressing After Anthracycline and Taxane Treatment
|Journal of Clinical Oncology|2007|483